In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Lonza Group AG

http://www.lonza.com

Latest From Lonza Group AG

Coronavirus Update: BARDA Funding Rises To $955m As Moderna Expands Phase III Trial

Moderna has updated its protocol, expanding its recruitment target to 30,000 and aiming for more ethnically diverse and at-risk groups to be included. 

Coronavirus COVID-19 Clinical Trials

Fosun’s IPO Plan For India’s Gland Hits Multiple Targets

With a proposed IPO, Gland Pharma’s parent company, Fosun Pharma, hopes to raise funds for its injectables business and possibly its COVID-19 vaccine. The move will also cut Chinese ownership against a backdrop of shaky relations between India and China. As investors warm up to pharma stocks, the timing seems right.

Commercial Financing

COVID-19 Vaccine Manufacturing: Moderna CEO Worries Most About Raw Materials

Moderna's Bencal and Merck Vaccine head Markels discuss the difficulties in scaling up manufacturing capacity for vaccine candidates at BIO plenary session; CEPI CEO says his organization can help facilitate pairing of vaccine development partners.

Coronavirus COVID-19 Vaccines

Moderna Phase III COVID-19 Vaccine Plan To Enroll 30,000 Patients

The company finalized the Phase III program based on feedback from the US FDA and plans to start the study in July. With a 100 µg dose, Moderna says it can manufacture 500 million doses a year.

Coronavirus COVID-19 Vaccines
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Diversified
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Services
  • Contract Manufacturing Organization
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • Algonomics NV
    • Capsugel S.A.
    • HansaBioMed Life Sciences OÜ
    • InterHealth Nutraceuticals, Inc.
    • Lonza Group Ltd.
    • MODA Technology
    • Micro-Macinazione S.A.
    • PharmaCell B.V.
UsernamePublicRestriction

Register